雪茶
Lv4
570 积分
2021-06-04 加入
-
Challenges and Opportunities in Achieving Asthma Remission
8天前
已完结
-
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia
12天前
已关闭
-
Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis
26天前
已完结
-
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
26天前
已完结
-
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
26天前
已完结
-
Antimicrobial activity of new anti-Pseudomonas beta-lactam-beta-lactamase inhibitors against Pseudomonas aeruginosa respiratory isolates recovered during the study for Monitoring Antimicrobial Resistance Trends (SMART) program in France (2016–2022)
27天前
已完结
-
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa
27天前
已完结
-
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China (2024)
28天前
已完结
-
Three ways to combat antimicrobial resistance
1个月前
已完结
-
Identification and management of cardiopulmonary risk in patients with COPD: a multidisciplinary consensus and modified Delphi study
1个月前
已完结